Teva buys rights to prostate cancer drug

Teva buys rights to prostate cancer drug
Ha'aretz - 9 minutes ago
By Yoram Gabison TheMarker Correspondent and Reuters Teva Pharmaceutical Industries is preparing for the evil day that a rival company begins selling a copycat version of its blockbuster drug ...